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ABSTRACT
Objectives. This paper aims to inves-
tigate the prevalence and severity of 
hand and wrist joints power Doppler 
(PD) ultrasound (US) detected abnor-
malities in systemic sclerosis (SSc). 
Methods. Hand and wrist joints of 46 
consecutive SSc patients and 15 healthy 
controls were studied by using PDUS. 
Each joint was evaluated for the pres-
ence of effusion, synovial hypertrophy, 
hyperaemia, bone erosions and corti-
cal irregularities; in addition, local 
tendons for tenosynovitis and hyperae-
mia, and median nerve for entrapment 
neuropathy were examined.
Results. Synovial hypertrophy was 
detected in 3% hand joints and in 
46% wrists of SSc patients, with sig-
nificant differences respect to controls 
(p=0.000004 and 0.000001, respective-
ly). The prevalence of PD positivity was 
significantly higher in patients’ hand 
joints (1.7%, p=0.001527) and wrists 
(43%, p=0.000001) than in healthy in-
dividuals. Seven percent of hand and 
54% of wrist joints resulted to be posi-
tive for joint effusion with significant 
differences from controls (p=0.000001 
and p=0.000013, respectively). The 
prevalence of cortical irregularities 
was significantly higher (p=0.006) than 
healthy subjects only at hand joints lev-
el. No significant difference was found 
for bone erosions. Tenosynovitis was 
found in 6% out of the 1.196 synovial 
tendon sites examined of SSc patients 
with significant differences compared 
to healthy subjects (p=0.000001); PD 
resulted to be positive in 29% of them, 
with significantly differences compared 
to controls (p=0.0038). 
Conclusion. This study, focused on 
hand and wrist joints PDUS assessment 
of inflammatory and structural abnor-
malities in SSc, demonstrated a varied 
and complex involvement both at joint 
and periarticular tissues level, show-
ing that wrists were more frequently the 
site of inflammatory findings.
Introduction
Systemic sclerosis (SSc) is a chronic 
connective tissue disease characterised 
by microvascular damage and deposi-
tion of collagen in the skin and internal 
organs. Its etiology and pathogenesis 
have not been clearly identified, yet. 
Patients with SSc are usually young 
or middle-age women (female-to-male 
ratio approximately 8:2), and often de-
velop joint involvement, especially at 
the level of the hands and feet, with 
arthralgia and/or arthritis and/or flex-
ion contractures (1-5). Articular in-
volvement constitutes a determinant of 
disability and is usually evaluated by 
clinical examination and conventional 
radiography. The main hand radiologic 
features are represented by erosions, 
joint space narrowing, demineralisa-
tion, acro-osteolysis, flexion contrac-
ture and calcinosis (3, 4, 6, 7). 
Musculoskeletal ultrasound (US) is a 
useful imaging tool to assess joint and 
soft tissue involvement in connective 
tissue diseases (8); it is a harmless, non-
invasive and relatively low-cost tech-
nique that can give useful information 
about a wide range of abnormalities 
appearing at joint and soft tissue levels 
in rheumatic patients. Particularly in 
recent years, US has proved to have a 
relevant role in the assessment of joint 
inflammation and structural alterations 
in patients with different rheumatic dis-
orders. Using US, it is possible to study 
synovial joints and periarticular soft tis-
sues for the occurrence of inflammatory 
lesions (such as synovitis, tenosynovitis 
and bursitis), bone changes and carti-
laginous abnormalities (9-17). More-
over, the use of power Doppler (PD) 
modality allows to study local vascu-
larisation and to detect the presence of 
pathological hyperaemia, which is con-
sidered as an index of active inflamma-
tion (18). The role of US in the assess-
ment of musculoskeletal abnormalities 
in SSc patients is yet to be defined and 
only limited focus on the evaluation of 
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hand and wrist joint changes has been 
developed so far, even though this often 
represents a serious concern in that dis-
ease (8). Thus, by using US combined 
with PD and including both assessment 
of inflammatory changes and structural 
alterations, the aims of the present study 
were to investigate the prevalence and 
severity of hand and wrist joints abnor-
malities in SSc patients and to compare 
PD-US-detected findings with clinical 
and laboratory data.
Patients and methods
Forty-six patients with SSc consecutive-
ly admitted to the outpatient clinic of the 
Rheumatology Unit of Sapienza Uni-
versità di Roma and fulfilling the pre-
liminary American College of Rheuma-
tology (ACR) criteria for the classifica-
tion of SSc were investigated (19). The 
presence of any other rheumatic disease 
or of an overlap syndrome was an ex-
clusion criterion for the patients enrol-
ment. In addition, 15 healthy subjects, 
selected among the staff of our Rheuma-
tology unit on the basis of a voluntary 
enrolment, were examined as controls. 
Informed consent was obtained from all 
participants according to the declaration 
of Helsinki. The study was approved by 
local ethic committee. 
All patients and controls underwent 
clinical evaluation, laboratory tests and 
PD-US assessment in the same day. 
Clinical and laboratory assessment
An expert rheumatologist, blinded to 
ultrasonographic findings, performed 
a detailed clinical assessment includ-
ing evaluation of different organs and 
systems (lung, esophagus, heart, cu-
tis), hand and wrist joints involvement 
(pain, swelling, functional limitation 
and tendon friction rubs), naifold cap-
illaroscopy, and laboratory investiga-
tions (blood cell count, erythrocyte 
sedimentation rate [ESR], C-reactive 
protein [CRP], complement fractions 
C3 and C4, renal function evaluation, 
antinuclear antibodies, including anti-
centromere antibodies [ACA], antibod-
ies against topoisomerase I [Scl-70]). 
US examination
After clinical assessment and on the 
same day, US examination was per-
formed by an expert rheumatologist, 
blinded to clinical and laboratory fea-
tures either if the subjects were SSc 
patients or healthy controls, who as-
sessed, bilaterally, wrist and hand joints 
(radio-ulno-carpal [RUC], inter-carpal 
[IC], carpo-metacarpal [CMC], meta-
carpophalangeal [MCP], proximal in-
terphalangeal [PIP], distal interphalan-
geal joints [DIP]), flexor and extensor 
tendons at hand and wrist level (1°-6° 
extensor compartments, flexor carpi ra-
dialis, flexor digitorum superficialis and 
profundus, flexor pollicis longus, 2° 
digitorum flexor tendons, 3° digitorum 
flexors, 4° digitorum flexors, 5° digi-
torum flexors), and the median nerve. 
The US examination was conducted by 
using a multiplanar scanning technique, 
according to published guidelines (12-
17, 20). A Logiq9 machine (General 
Electric, Medical Systems, Milwaukee, 
WI, USA) equipped with a 9–15 lin-
ear probe was used (gain 50%) and PD 
(7.5MHz; gain 50%; PRF 0.5kHz, low 
filter) was applied to assess local syno-
vial vascularisation. Each joint was 
evaluated for the presence of effusion, 
synovial hypertrophy, hyperaemia, 
bone erosions and cortical irregulari-
ties; in addition, local tendons for the 
occurrence of tenosynovitis and hyper-
aemia, and median nerve for assess-
ment of cross sectional area were exam-
ined. All abnormalities were registered 
according to the reported definitions of 
the literature, as follows (21-23): joint 
effusion as an abnormal hypoechoic or 
anechoic intra-articular material that is 
displaceable and compressible, but does 
not exhibit Doppler signal; synovial hy-
pertrophy as an abnormal hypoechoic 
intra-articular tissue non-displaceable 
and poorly compressible and which 
may exhibit Doppler signal; bone ero-
sions as an intra-articular discontinuity 
of the bone surface that is visible in 2 
perpendicular planes; cortical irregu-
larities as loss of continuity of cortical 
bone without any clear evidence of ero-
sion/osteophyte/fracture; tenosynovitis 
as hypoechoic or anaechoic thickened 
tissue with or without fluid within the 
tendon sheath, which is seen in 2 per-
pendicular planes and which may ex-
hibit Doppler signal; increased median 
nerve cross sectional area (>12 mm²). 
A 4-point-semi-quantitative-scale (0–3: 
0=absent; 1=mild; 2=moderate; 3=se-
vere) was used to indicate the degree of 
effusion, synovial hypertrophy and PD 
signal at joint level (24). A similar scor-
ing system was used to determine the 
grade of tenosynovitis. Bone erosions 
and abnormal median nerve were as-
sessed on a dichotomous scale (present/
absent).
Statistical analysis
Data were presented as mean+SD. Cat-
egorical data were analysed using Fish-
er’s exact two-tailed test. Differences 
between groups were analysed using 
the Mann-Whitney U-test. A value of 
p<0.05 was considered as statistically 
significant.
                               
Results
Demographic, clinical and laboratory 
findings in SSc patients and in healthy 
subjects are reported in Tables I and II. 
We investigated 46 patients (42 wom-
en and 4 men; median age 62 years, 
range 38–77) with SSc, consecutively 
referring to our Rheumatology Unit; 
mean disease duration was 136 months 
(range 7–528); 28 patients had a limit-
ed (lcSSc) form (2 men and 26 women; 
median age 64 [range 39–77]; mean 
disease duration 128 months [range 
7–328]) and 18 a diffuse (dcSSc) (2 
women and 16 men; median age 56 
[range 39–76]; mean disease duration 
149 months [range 24–528]) form of 
disease. Treatment included low dose 
of prednisone (4/5 mg/day) (15 dc-
SSc and 10 lcSSc), DMARDS therapy 
(5 dcSSc and 5 lcSSc), vasodilatators 
(16 dcSSc and 19 lcSSc), antiplatet (8 
dcSSc and 25 lcSSc) and NSAIDs (4 
dcSSc and 6 lcSSc) drugs. In addition, 
15 healthy subjects, selected among the 
staff of our Rheumatology unit on the 
basis of a voluntary enrolment, were 
examined as controls (10 women and 
5 men; median age 51 years, range 
30–59).
Clinical evaluation of hand and wrist 
joints revealed the following findings: 
painful joints in 29 out of 92 (31.5%) 
wrists, 56 out of 460 (12%) MCP, 68 
out of 460 (14.7%) PIP, 46 out of 368 
DIP (12.5%) and in 4 out of 92 (4.3%) 
CMC joints. Swollen joints were de-
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tected in 8 out of 92 (8.7%) wrists, 
23 out of 460 (5%) MCP, 61 out of 
460 (13.2%) PIP and in 45 out of 368 
(12.2%) DIP joints. Limited motion was 
found in 17 out of 92 (18.4%) wrists, 
65 out of 460 (14.1%) MCP, 94 out of 
460 (20.4%) PIP and in 106 out of 368 
(28.8%) DIP joints. Globally, at wrist 
level pain was found in 17 patients (7 
lcSSc and 10 dcSSc), swelling in 4 (1 
lcSSc and 3 dcSSc) and functional limi-
tation in 13 patients (3 lcSSc and 10 
dcSSc); at hand level pain was present 
in 18 patients (12 lcSSc and 6 dcSSc), 
swelling in 14 (10 lcSSc and 4 dcSSc) 
and functional limitation in 28 patients 
(12 lcSSc and 16 dcSSc); 10 patients (2 
lcSSc and 8 dcSSc) presented tendon 
friction rubs (TFR) (Table II).
Serological parameters showed ESR 
median as 21.8 mm/h (range 4–62); 
CRP was positive in 6 patients; 25 
and 14 resulted positive for ACA and 
Scl70 antibodies, respectively; hypo-
complementaemia was present in only 
3 patients. All differences regarding 
clinical and laboratory assessment be-
tween lcSSc and dcSSc subgroups are 
reported in Table I. Ultrasonographic 
features at hand and wrist joints and 
tendons level are reported in Tables III, 
IV, V, VI and VII and in Figure 1. 
In particular, synovial hypertrophy was 
detected in 3% of hand and in 46% 
wrist joints of SSc patients (Fig. 1A), of 
with significant differences compared 
to controls (p=0.000004 and 0.000001, 
respectively). The prevalence of PD 
positivity was significantly higher in pa-
tients’ hand joints (1.7%, p=0.001527) 
and wrist joints (43%, p=0.000001) 
than in healthy individuals. Regard-
ing the finding of joint effusion, 7% of 
hand and 54% of wrist joints resulted 
to be positive for that abnormality with 
significant differences compared to 
controls (p=0.000001 and p=0.000013, 
respectively) (Table III). 
No significant difference was found for 
the evidence of bone erosions both at 
hand and wrist level. The prevalence of 
cortical irregularities was significantly 
higher (p=0.006) than in healthy sub-
jects only at hand joint level. 
The US analysis of the degree of sin-
gle abnormalities at different joint sites 
(Table IV) demonstrated that signifi-
Table I. Demographic, organs and laboratory features in patients and healthy subjects.
Demographic, organs and laboratory SSc (n=46) lcSSc (n=28) dcSSc (n=18) HS (n=15) 
features 
Gender: men/women (ratio) 4/42 (0.095) 2/26 2/16 5/10 (0.5)
Age: mean (range), years 62 (38–77) 64 (39–77) 56 (39–76)    51 (30–59)
Disease duration: mean (range), months 136 (7–528) 128 (7–384) 149 (24–528) –
Pulmonary hypertension: yes/no 15/31 9/19 6/12 –
Lung fibrosis: yes/no 25/21 12/16 13/5 –
Esophageal involvement: yes/no 31/15 15/13 16/2 –
Ulcers: yes/no 19/27 8/20 11/7 –
Skin score: ≥14/<14 15/31 2/26 13/5 –
Videocapillaroscopy: late/early or active 16/30 6/22 10/8 –
ESR: mean 21.8 mm/h 24.2 mm/h 17.7 mm/h –
CRP: positive/negative 6/40 4/24 2/16 –
ACA positive 25 21 4 –
Scl-70 positive 14 3 11 –
Hypocomplementaemia: yes/no 3/43 1/27 2/16 – 
 
SSc: total  patients with systemic sclerosis; lcSSc: patients with limited form of systemic sclerosis; 
dcSSc: patients with diffuse form of systemic sclerosis; HS: healthy subjects; ESR: erythrocyte sedi-
mentation rate; CRP: C-reactive protein; ACA: anti-centromere antibodies; Scl-70: antibodies against 
topoisomerase I.                 
Table II. Hand and wrist involvement in patients and healthy subjects.
Findings  SSc (n=46) lcSSc (n=28) dcSSc (n=18) HS (n=15)
Wrist pain: yes/no 17/29 7/21 10/8 –
Hand pain: yes/no 18/28 12/16 6/12 –
Wrist swelling: yes/no 4/42 1/27 3/13 –
Hand swelling: yes/no 14/32 10/18 4/14 –
Functional limitation wrist: yes/no 13/33 3/25 10/8 –
Functional limitation hand: yes/no 28/18 12/16 16/2 –
Tendon friction rubs: yes/no 10/36 2/26 8/10 – 
     
SSc: total patients with systemic sclerosis; lcSSc: patients with limited form of systemic sclerosis; 
dcSSc: patients with diffuse form of systemic sclerosis; HS: healthy subjects.
Table III. Ultrasonographic findings in hand and wrist joints of SSc patients and healthy 
subjects: numbers of involved joints.
US findings Synovial Power Joint Erosions Cortical
 hypertrophy Doppler effusion SSc/HS irregularities
 SSc/HS SSc/HS SSc/HS p-value SSc/HS
 p-value p-value p-value  p-value   
MCP 21 (4.6%)/0 13 (2.8%)/0 49 (10.6%)/1(3.3%) 3 (0.6%)/0 1 (0.2%)/0
 p=0.003560 p=0.045447 p=0.000010 n.s. n.s  
PIP 20 (4.3%)/0 8 (1.8%)/0 42 (9.9%)/0 0/0 9 (1.9%)/0
 p=0.006121 n.s. p=0.000007 n.s. n.s.
DIP 3 (0.8%)/0 3 (0.8%)/0 14 (3.8%)/0 0/0 9 (2.4%)/0
 n.s. n.s. p=0.026434 n.s. n.s.
IC 1 (1.1%)/0 1(1.1%)/0 1 (1.1%)/0 0/0 0/0
 n.s. n.s. n.s. n.s. n.s.
CMC 0/0 0/0 0/0 0/0 0/0
 n.s. n.s. n.s. n.s. n.s.
Total hand joints 45 (3%)/0 25 (1.7%)/0 106 (7%)/0 3 (0.2%)/0 19 (1.3%)/0 
   involvement p=0.000004 p=0.001527 p=0.000001  n.s. p=0.006
RUC  44 (46%)/0 40 (43%)/0 50 (54%)/3(10%) 2 (2%)/0 2 (2%)/0
 p=0.000001 p=0.000001 p=0.000013 n.s. n.s.
MCP: metacarpophalangeal; PIP: proximal interphalangeal; DIP: distal interphalangeal; IC: intercar-
pal; CMC: carpo-metacarpal; RUC: radio-ulno-carpal; SSc: numbers of involved joints in total patients 
(n=46) with systemic sclerosis; HS: numbers of involved joints in healthy subjects. n.s.: non significa-
tive p-value.
S-92
PDUS in systemic sclerosis / A. Iagnocco et al.
cant differences between SSc patients’ 
joints and controls were present, at hand 
level, for the findings of mild synovial 
hypertrophy (p=0.000211), severe PD 
positivity (p=0.027) and mild effusion 
(p=0.000001); at wrist level, for mild 
(p=0.000971) and moderate (p=0.027) 
synovial hypertrophy, mild (p=0.0042) 
and moderate (p=0.027) PD positivity 
and mild effusion (p=0.019068). 
Regarding tendon involvement (Table 
V), B-mode ultrasonographic signs of 
tenosynovitis (Fig. 1B) were found in 
6% out of the 1196 synovial tendon 
sites examined with significant differ-
ences compared to healthy subjects 
(p=0.000001); PD resulted to be posi-
tive in 29% of them, a value that re-
sulted to be significantly different from 
controls (p=0.0038). 
Considering findings at patient level (Ta-
bles VI and VII), US correlations were 
performed comparing lcSSc (n=28) to 
dcSSc (n=18) patients, total SSc patients 
(n=46) to controls (n=15), and also com-
paring separately lcSSc and dcSSc sub-
group to controls. No significant US dif-
ferences were found between lcSSc and 
dcSSc subgroups (p=n.s.).
Regarding relation between total SSc 
and controls (Table VI), joint effu-
sion was present in the hand joints of 
50% of the patients and in 6.7% of the 
controls (p=0.002533); the wrist had a 
significantly higher and more complex 
involvement, with evidence of synovial 
hypertrophy in 63% (p=0.000009), PD 
positivity in 61% (p=0.000015) and ef-
fusion in 69.5% (p=0.000196) of cases. 
The prevalence of bone erosions and 
cortical irregularities was not signifi-
cantly higher in patients than in healthy 
controls. 
Tenosynovitis was found in 43.5% of 
patients with SSc and only in 6.7% of 
controls (p=0.01), without any signifi-
cant differences regarding the finding 
of local PD positivity (Table VII).
Increased cross-sectional area of me-
Table IV. Grade of synovial hypertrophy, power Doppler and effusion in hand and wrist joints of SSc patients and healthy subjects.
US findings Synovial hypertrophy Power Doppler Joint effusion
 SSc/HS p-value SSc/HS p-value SSc/HS p-value
 mild moderate severe mild moderate severe mild moderate severe
1° MCP 0/0 1/0 1/0 1/0 1/0 1/0 9/0 1/0 0/0
2° MCP 7/0 1/0 0/0 2/0 0/0 2/0 12/1 1/0 1/0
3° MCP 4/0 1/0 0/0 1/0 0/0 1/0 9/0 1/0 1/0
4° MCP 2/0 0/0 1/0 0/0 0/0 2/0 6/0 0/0 2/0
5° MCP 2/0 0/0 1/0 0/0 0/0 2/0 4/0 0/0 2/0
1° IP 2/0 1/0 0/0 2/0 0/0 0/0 3/0 3/0 0/0
2° PIP 4/0 1/0 0/0 0/0 1/0 1/0 10/0 1/0 1/0
3° PIP 2/0 1/0 0/0 0/0 0/0 1/0 7/0 1/0 1/0
4° PIP 4/0 0/0 1/0 1/0 0/0 1/0 9/0 0/0 1/0
5° PIP 2/0 0/0 1/0 0/0 0/0 1/0 4/0 0/0 1/0
2° DIP 0/0 0/0 0/0 0/0 0/0 0/0 5/0 1/0 0/0 
3° DIP 1/0 1/0 1/0 1/0 0/0 2/0 4/0 0/0 1/0
4° DIP 0/0 0/0 0/0 0/0 0/0 0/0 1/0 0/0 0/0
5° DIP 0/0 0/0 0/0 0/0 0/0 0/0 2/0 0/0 0/0
IC 1/0 0/0 0/0 1/0 0/0 0/0 1/0 0/0 0/0
CMC 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0 0/0
Total hand joints involvement 31/0 7/0 6/0 9/0 2/0 14/0 86/1 9/0 11/0
 p=0.000211 n.s. n.s. n.s. n.s. p=0.027 p=0.000001  n.s. n.s.
RUC 27/0 14/0 3/0 22/0 14/0 4/0 34/3 6/0 10/0
 p=0.000971 p=0.027 n.s. p=0.0042 p=0.027 n.s. p=0.019068 n.s. n.s.
MCP: metacarpophalangeal; IP: interphalangeal; PIP: proximal interphalangeal; DIP: distal interphalangeal; IC: intercarpal; CMC: carpo-metacarpal; RUC: 
radio-ulno-carpal; SSc: numbers of involved joints in total patients (n=46) with systemic sclerosis; HS: numbers of involved joints in healthy subjects. n.s.: 
non significative p-value.
Table V. Ultrasonographic findings in extensor and flexor tendons in SSc patients and 
healthy subjects. 
Number of synovial tendon sites totally examined in SSc: 1.196, and in healthy subjects: 390.
Tendons  B-mode tenosynovitis Positive power Doppler 
 SSc/HS p-value  SSc/HS p-value
1° extensor compartment 3/0 1/0
2° extensor compartment 4/0 2/0
3° extensor compartment 4/0 0/0
4° extensor compartment 14/0 4/0
5° extensor compartment 1/0 0/0
6° extensor compartment 5/0 1/0
Flexor carpi radialis 1/0 1/0
Flexor digitorum superficialis and profundus 1/0 1/0
Flexor pollicis longus 3/0 2/0
2° digitorum flexor tendons 8/1 3/0
3° digitorum flexors 13/0 2/0
4° digitorum flexors 9/0 2/0
5° digitorum flexors 6/0 2/0
Total tendons involvement    72 (6%)/1 (0.26%) 21 (29%)/0
 p=0.000001   p=0.0038          
SSc: numbers of involved tendons in total patients (n=46) with systemic sclerosis; HS: numbers of 
involved joints in healthy subjects.
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dian nerve at carpal tunnel was found 
in 2 SSc cases and in none of the con-
trols (n.s.).
Comparing lcSSc subgroup to controls, 
significant correlation were present at 
hand for the occurrence of joint effusion 
(16 lcSSc vs. 1 controls; p=0.001246) 
and synovial hypertrophy (9 lcSSc vs. 
0 controls; p=0.000151); at wrist joint 
effusion was found in 19 lcSSc vs. 2 
controls (p=0.0001062), both syno-
vial hypertrophy and PD positivity in 
16 lcSSc vs. 0 controls (p=0.000151) 
(Table VI); US signs of tenosynovitis 
(Table VII) were present in 11 lcSSc 
and only in 1 control (p=0.032719), 
without any significant differences re-
garding local PD positivity. No others 
differences were present.
Results between dcSSc subgroup and 
controls showed the following find-
ings: at hand level joint effusion was 
present in 7 dcSSc and in 1 controls 
(p=0.046339), while at wrist a more 
complex involvement was evident with 
joint effusion in 13 dcSSc vs. 2 controls 
(p=0.001286), synovial hypertrophy in 
13 dcSSc (p=0.000029) and PD posi-
tivity in 12 dcSSc (p=0.000054) (Table 
VI); tenosynovitis was present in 9 dc-
SSc (p=0.001390), without differences 
for local PD positivity (Table VII). No 
other differences were found.
Correlation between US features 
and clinical/serological findings
Statistical correlations between US find-
ings and clinical/serological assessment 
were performed for total patients (46), 
and also separately for lcSSc (28) and 
dcSSc (18) subgroups. 
A statistically significant correlation 
was found between joint effusion and 
pain at hand level considering total (46) 
SSc patients (p=0.033108), and between 
PD positivity and swelling at wrist lev-
el in lcSSc subgroup (p=0.0401026); 
no other significant correlations were 
found between US findings and clini-
cal articular assessment (pain, swelling, 
functional limitation) in total SSc and in 
2 subgroups. The occurence of TFR was 
not statistically related to US signs of 
tenosynovitis.
No significant correlations were pre-
sent between US features and follow-
ing findings: ulcers (present/absent), 
skin involvement (skin score, cut off 
≥14), disease duration (cut off ≥120 
months), naifold capillaroscopy (pat-
tern late vs. early or active). 
CRP positive was not related to PD 
positivity on wrist and hand joints, and 
on tendon level.
Discussion and conclusions
The present US study, performed at 
hand and wrist level in patients with 
SSc, investigated the abnormalities of 
both joints and periarticular structures, 
and showed a diffuse involvement in 
all synovial structures examined, with 
Table VI. US findings in hand and wrist, numbers of involved subjects.
  Synovial Power Joint Erosions Cortical   
   hypertrophy Doppler effusion  irregularities
lcSSc/dcSSC Hand involvement 9/2 5/2 16/7 3/0 2/0                   
p-value  n.s. n.s. n.s.  n.s.  n.s.
 Wrist involvement 16/13 16/12 19/13 1/0 0/1
  n.s. n.s. n.s.  n.s.  n.s.
SSc/HS Hand involvement 11/0 7/0 23/1 3/0 2/0                                     
p-value  n.s.  n.s. p=0.002533  n.s. n.s.
 Wrist involvement 29/9 28/0 32/2 1/0 1/0
  p=0.000009 p=0.000015 p=0.000196 n.s. n.s.
lcSSc/HS Hand involvement 9/0 5/0 16/1 3/0 2/0
p-value                         p=0.016890 n.s. p=0.001246 n.s. n.s.
 Wrist involvement 16/0 16/0 19/2 1/0 0/0
  p=0.000151 p=0.000151 p=0.001062   n.s. n.s.
dcSSc/HS Hand involvement 2/0 2/0 7/1 0/0 0/0
p-value                                          n.s. n.s. p=0.046339  n.s. n.s.
 Wrist involvement 13/0 12/0 13/2 0/0 1/0                     
  p=0.000029 p=0.000054 p=0.001286  n.s. n.s.
SSc: total patients with systemic sclerosis (n=46); lcSSc: patients with limited form (n=28); dcSSc: patients with diffuse form (n=18); HS: heathy subjects 
(n=15);  n.s.: non significative p-value.
Table VII. US findings in hand and wrist tendons, numbers of involved  subjects.
 
 B-mode tenosynovitis Power Doppler
lcSSc/dcSSc 11/9 1/4 
p-value                                                    n.s. n.s.
SSc/HS 20/1 5/0
p-value p=0.01 n.s.
lcSSc/HS 11/1 1/0
p-value p=0.032719  n.s.
dcSSc/HS 9/0 4/0
p-value p=0.001390 n.s.
SSc: total patients with systemic sclerosis (n=46); lcSSc: patients with limited form (n=28); dcSSc: 
patients with diffuse form (n=18); HS: heathy subjects (n=15); n.s.: non significative p-value.
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the presence of mild-to-severe inflam-
mation.
During recent years a widespread ap-
plication of musculoskeletal US has 
been registered with an increasing 
number of publications in the field of 
inflammatory arthritis, osteoarthritis 
and connective tissue diseases (8, 9; 
12-17, 25, 26). However, only limited 
focus in SSc has developed so far and 
the few papers devoted to the analysis 
of that disease have either assessed ex-
clusively joint involvement or median 
nerve entrapment syndrome or have 
been performed with the aim of com-
paring magnetic resonance imaging to 
US for the detection of inflammatory 
arthritis in selected symptomatic cases 
(27-30).
Our study demonstrated a high preva-
lence of involvement at hand and wrist 
joints level, particularly regarding the 
presence of inflammatory findings and 
with evidence of synovial hypertrophy, 
PD signs of active local inflammation 
and joint effusion. These abnormali-
ties represent the single components of 
synovitis and, therefore, their presence 
in the examined joints is consistent 
with the presence of diffuse inflamma-
tory involvement. Our results seem to 
be of interest, particularly when com-
pared to clinical assessment: indeed, 
most of our patients had no clinical 
signs of musculoskeletal involvement 
and few of them had physical find-
ings of arthritis. Interestingly, the US 
findings of inflammation have been 
demonstrated both in the dcSSc and 
lcSSc forms, indicating that musculo-
skeletal involvement may be present in 
both subsets of the disease; indeed, no 
significant differences were revealed 
comparing the US findings in dcSSc to 
lcSSc (Tables VI and VII).
In addition, when the grade of local 
involvement was evaluated, we found 
that hand joints, besides being the site 
of mild effusion, were also character-
ised by mild synovial hypertrophy, 
which was accompanied by a severe PD 
signal. This last finding, demonstrating 
the presence of a highly active inflam-
mation, represents a novel aspect of 
hand joint involvement in SSc, which 
needs further evaluations. On the other 
hand, the presence of mild to moderate 
involvement for all the 3 findings that 
are consistent with joint synovitis was 
demonstrated at wrist level.
The evaluation of joint structural dam-
age lesions showed that bone erosions 
were not relevant abnormalities, while 
cortical irregularities may represent an 
interesting finding to be considered in 
the evaluation of SSc patients.
Our findings are partially in agreement 
with the study of Cuomo et al. who 
analysed, only at a global patient level, 
different US aspects of hand and wrist 
joint involvement and, compared to our 
results, showed a higher prevalence of 
structural damage lesions and a lower 
number of cases with inflammatory 
findings, which were particularly evi-
dent at the hand joints (27). 
In addition, our research evaluated a 
huge number of tendons for the detec-
tion of tenosynovitis. Similarly to Chi-
tale et al., we found a high prevalence 
of B-mode tenosynovitis at the level of 
all local extensor and flexor tendons 
and, interestingly, active inflamma-
tion, as demonstrated by PD assess-
ment, was detected in a great number 
of synovial tendon sites (29); further-
more, considering the evaluation of 
erosion, our findings are in line with 
results reported by Chitale et al., who 
did not find erosions on US. However, 
Chitale et al., in the same study and in 
the same patients, and also Low et al., 
described a significant presence of ero-
sions using magnetic resonance (MRI) 
in SSc; so it is possible to hypothesise 
that US presents limitations in detect-
ing erosions in SSc due to limited 
acoustic windows in certain joints (29, 
31).Unlike the other reports focused on 
the US evaluation of median nerve in-
volvement at carpal tunnel in SSc and 
showing a high prevalence of nerve ab-
normalities, only 2 of our patients dem-
onstrated to have sonographic signs of 
carpal tunnel syndrome (28, 30).
SSc is a chronic connective tissue dis-
ease characterised by musculoskeletal 
involvement in more than 30% of cas-
es; this may be determinant for func-
tional disability, in some cases. Articu-
lar involvement has been demonstrated 
by several studies (3, 4, 32, 33). How-
ever, imaging evaluation has registered 
only limited focus so far, by applying 
Fig. 1. PDUS of the hand and wrist in systemic sclerosis.
A: Dorsal longitudinal scan of the wrist joint with evidence of  synovial hypertrophy, joint effusion and PD positivity. 
B: Palmar transverse scan of the 3° finger showing tenosynovitis of the flexor tendons with PD positivity. 
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either magnetic resonance imaging or 
US or conventional radiography for the 
examination of bone abnormalities (3, 
27, 29, 31, 34).
In conclusion, the present US study, 
demonstrating a varied and complex 
involvement at hand and wrist joint 
level both in dcSSc and lcSSc forms, 
without significant differences between 
the 2 subsets, represents an interesting 
contribution to a more complete imag-
ing evaluation of musculoskeletal ab-
normalities in SSc patients. 
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